HNF4G and cancer: These findings suggest that HNF4G mRNA levels and transcriptional activity increase when cells transition from normal to cancer, that HNF4G and FOXA1 are the key lineage-defining transcription factors in PDAC and that amplification of HNF4G is a common event that correlates with poor outcome.